Back

Association of early dapagliflozin initiation with subclinical changes in cardiac function during anticancer therapy

19 June 2026 (16:00 - 16:15)
Organised by: Logo
Congress Presentation Part of: Preventing cardiotoxicity Stratification, Prevention and Monitoring Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Associate Professor Lusine Hazarapetyan

Yerevan MSC, Yerevan (Armenia)

2 More presentations in this session

Presentation thumbnail
Cardioprotective effects of medical therapy for cancer therapy-related cardiac dysfunction: a systematic review and meta-analysis
Ms Y. Appels (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Sacubitril/valsartan in anthracycline-treated patients: a systematic review and meta-analysis of available evidence.
Doctor M. Camilli (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Preventing cardiotoxicity
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 16:00 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources